Interpreting Peripheral Blood Smears¶
Chapter 65 | Part 2: Cardinal Manifestations and Presentation of Diseases
KEY CLINICAL POINTS¶
- RDW (Red Cell Distribution Width) reflects red cell size variation; normal range 11–14%, increases to 15–18% in microcytic anemia with morphologic anisocytosis.
- Platelet examination: Count 5–6 fields, estimate platelet count (1:20 ratio with red cells), recognize large platelets as markers of marrow dysfunction or rare syndromes.
- Poikilocytosis (abnormal red cell shapes) includes spherocytes (hereditary spherocytosis), elliptocytes (membrane defects), schistocytes (microangiopathic hemolysis), and acanthocytes (liver disease/abetalipoproteinemia).
- White cell morphology: Hypersegmented neutrophils (B12/folic acid deficiency), Pelger-Hüet anomaly (benign nuclear abnormality), Döhle bodies (infection/toxicity).
- Key differentials: Iron deficiency (hypochromic microcytic with high RDW) vs. thalassemia (uniform small cells with normal RDW).
1. DEFINITION & OVERVIEW¶
Peripheral blood smear analysis is a critical diagnostic tool for evaluating hematologic disorders. It assesses red cell morphology, platelet count, and white cell features. The red cell distribution width (RDW) quantifies size variation, calculated as (standard deviation of MCV ÷ mean MCV) × 100. Morphologic abnormalities include anisocytosis (size variation) and poikilocytosis (shape variation).
Red Cell Morphology and Associated Disorders¶
| Morphology | Description | Associated Conditions |
|---|---|---|
| Microcytic | Red cells <7 mm | Iron deficiency, thalassemia |
| Macrocytic | Red cells >100 fL | Vitamin B12/folic acid deficiency, megaloblastic anemia |
| Spherocytes | Small, round, hyperchromic | Hereditary spherocytosis, hemolytic anemia |
| Schistocytes | Helmet-shaped | Microangiopathic hemolysis, DIC |
| Acanthocytes | Spiculated | Liver disease, abetalipoproteinemia |
| Target cells | Central pallor with ring | Thalassemia, iron deficiency, liver disease |
1.1 Red Cell Morphology¶
Red cells are evaluated for size (MCV), color (normochromic/hypochromic), and shape (spherocytes, elliptocytes, schistocytes, etc.). Automated MCV aids classification, but clinical context is essential for accurate interpretation.
1.2 Platelet Assessment¶
Platelets are counted manually (5–6 fields) and evaluated for size, granularity, and clumping. Large platelets may indicate rapid turnover or marrow disease. Clumping can cause false counts due to anticoagulant effects.
1.3 White Cell Morphology¶
White cells are examined for nuclear segmentation (hypersegmented neutrophils), nuclear abnormalities (Pelger-Hüet anomaly), and inclusions (Döhle bodies).
2. EPIDEMIOLOGY¶
Peripheral blood smear abnormalities are common in hematologic disorders. Microcytic anemias (iron deficiency, thalassemia) and macrocytic anemias (B12/folic acid deficiency) are prevalent. Poikilocytosis is seen in hereditary disorders (e.g., elliptocytosis) and acquired conditions (e.g., uremia).
2.1 Risk Factors¶
Nutritional deficiencies (iron, B12), chronic disease, marrow dysfunction, and genetic disorders (e.g., hereditary spherocytosis).
2.2 Demographics¶
Iron deficiency anemia is most common in women of childbearing age; thalassemia is prevalent in Mediterranean/Asian populations; megaloblastic anemia is more common in older adults.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Red cell abnormalities arise from intrinsic defects (e.g., membrane, hemoglobin) or extrinsic factors (e.g., hemolysis, nutritional deficiencies). RDW increases with heterogeneous red cell size (e.g., iron deficiency) but remains normal in uniform small cells (thalassemia).
3.1 Red Cell Size Variation¶
RDW reflects standard deviation of MCV. Increased RDW indicates heterogeneous red cell size (e.g., iron deficiency) vs. uniform small cells (thalassemia).
3.2 Morphologic Abnormalities¶
Spherocytes result from membrane defects; schistocytes from microangiopathy; acanthocytes from lipid metabolism disorders; target cells from hemoglobinopathy or liver disease.
4. CLINICAL FEATURES¶
Symptoms depend on anemia severity (fatigue, pallor) or hemolysis (jaundice, splenomegaly). Physical findings include pallor, jaundice, splenomegaly, and abnormal red cell shapes on smear.
4.1 Anemia Types¶
Microcytic (iron deficiency, thalassemia), macrocytic (B12/folic acid deficiency), normocytic (chronic disease, hemolysis).
4.2 Hemolytic Signs¶
Jaundice, splenomegaly, reticulocytosis, and schistocytes on smear. Target cells may indicate hemoglobinopathy or liver disease.
5. DIFFERENTIAL DIAGNOSIS¶
Differentiate between iron deficiency (hypochromic microcytic with high RDW) and thalassemia (uniform small cells with normal RDW). Consider B12/folic acid deficiency for macrocytic anemia. Evaluate for hemolysis (schistocytes, reticulocytosis) or marrow disorders (teardrop cells, nucleated RBCs).
5.1 Microcytic Anemia¶
Iron deficiency vs. thalassemia: RDW (high vs. normal), hypochromia (present vs. absent), and presence of basophilic stippling (lead poisoning).
5.2 Macrocytic Anemia¶
Vitamin B12/folic acid deficiency vs. alcoholism: RDW (normal vs. high), presence of megaloblasts, and neurological symptoms (B12 deficiency).
6. INVESTIGATIONS & DIAGNOSIS¶
Laboratory tests include CBC with RDW, reticulocyte count, iron studies, and vitamin B12/folic acid levels. Wright-stained smears are essential for detecting inclusions (Howell-Jolly bodies, basophilic stippling) and abnormal morphology.
6.1 Diagnostic Criteria¶
RDW >15% suggests microcytic anemia; schistocytes confirm microangiopathic hemolysis; target cells indicate hemoglobinopathy or liver disease.
6.2 Artifacts¶
Platelet clumping (false low count), neutrophil fragmentation (false high platelet count), and dehydrated smears (artificial acanthocytes).
7. MANAGEMENT & TREATMENT¶
Treatment depends on underlying cause: iron supplementation for deficiency, B12/folic acid replacement, and addressing hemolysis (e.g., splenectomy for hereditary spherocytosis). Monitor response with follow-up CBC and RDW.
7.1 Pharmacologic Therapy¶
Iron supplements (ferrous sulfate), vitamin B12 injections, folic acid, and erythropoietin for anemia.
7.2 Monitoring¶
Repeat CBC, RDW, and iron studies to assess response. Monitor for complications (e.g., iron overload with chronic transfusions).
8. PROGNOSIS & COMPLICATIONS¶
Prognosis varies by etiology: iron deficiency is reversible, while thalassemia requires lifelong management. Complications include iron overload, splenic dysfunction, and marrow failure in severe cases.
8.1 Long-Term Risks¶
Chronic hemolysis may lead to gallstones, splenomegaly, and cardiovascular complications. Severe anemia can cause organ damage.
8.2 Special Populations¶
Pregnancy: Iron deficiency is common; monitor for anemia. Elderly: Anemia may be due to chronic disease or marrow failure.
10. KEY POINTS & CLINICAL PEARLS¶
- RDW is critical for differentiating iron deficiency from thalassemia. 2. Platelet clumping and anticoagulant artifacts can skew automated counts. 3. Schistocytes confirm microangiopathic hemolysis. 4. Target cells may indicate hemoglobinopathy or liver disease. 5. Manual smear review is essential for accurate diagnosis despite automated technology.